首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype
【24h】

DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype

机译:对主要胰岛素原73-90表位特异的DRB1 * 0401限制性人类T细胞克隆表达下调的T辅助2表型

获取原文
获取原文并翻译 | 示例
       

摘要

Recently, we have identified proinsulin (P-Ins)(73-90) as an immunodominant T cell epitope of HLA-DRB1*0401 (DR4) subjects with beta-islet cell autoimmunity and of HLA-DR4/CD4 double-transgenic mice immunized with human P-Ins. We have compared the fine specificities of one human CD4 T cell clone and two mouse T cell hybridoma clones recognizing this epitope, and, although these three clones all recognized the same core region (LALEGSLQK), there were major differences in how they interacted with the peptide (p)/HLA complex, reflecting the fact that human P-Ins is a foreign antigen in the mouse and an autoantigen in the type 1 diabetes patient. The human T cell clone was forkhead transcription factor 3 (Foxp3)-positive, a marker for regulatory T cell lineages, and secreted predominantly IL-5, IL-10, and low levels of IFN gamma in response to P-Ins(73-90). This finding is compatible with the previously detected regulatory cytokine pattern in subjects with P-cell autoimmunity. However, added N- or C-terminal amino acids drastically changed HLA and tetramer binding capacity as well as T cell reactivity and the cytokine phenotype of the P-Ins(73-90)-specific human CD4 T cell clone, suggesting a potential for this P-Ins epitope as a target for therapeutic intervention in HLA-DR4-positive humans with beta-islet cell autoimmunity or recent-onset type 1 diabetes.
机译:最近,我们已将胰岛素原(P-Ins)(73-90)确定为具有β胰岛细胞自身免疫性的HLA-DRB1 * 0401(DR4)受试者和已免疫HLA-DR4 / CD4双转基因小鼠的免疫优势T细胞表位与人的插件。我们已经比较了一个人CD4 T细胞克隆和两个小鼠T细胞杂交瘤克隆识别该表位的优良特异性,尽管这三个克隆都识别相同的核心区域(LALEGSLQK),但它们与细胞相互作用的方式却存在重大差异肽(p)/ HLA复合物,反映了人类P-Ins是小鼠中的外源抗原,是1型糖尿病患者中的自身抗原的事实。人类T细胞克隆呈叉头转录因子3(Foxp3)阳性,是调节性T细胞谱系的标志物,并主要针对P-Ins分泌IL-5,IL-10和低水平的IFNγ(73- 90)。该发现与先前在患有P细胞自身免疫的受试者中检测到的调节性细胞因子模式兼容。但是,添加的N或C末端氨基酸会极大地改变HLA和四聚体的结合能力,以及T细胞反应性和P-Ins(73-90)特异性人CD4 T细胞克隆的细胞因子表型,这表明可能这种P-Ins表位作为具有β-胰岛细胞自身免疫性或新近发生的1型糖尿病的HLA-DR4阳性人类的治疗干预目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号